胸主动脉腔内修复术后心力衰竭发生率
该荟萃分析纳入11项研究共30,680例TEVAR患者,评估术后30天内心力衰竭的原始发生率。
要点
- TEVAR术后30天内心力衰竭原始发生率为2.23%。
- 主动脉僵硬度增加和血流动力学改变可能减少冠脉供血。
- 建议围术期及术后加强心脏监测,尤其心血管高危患者。
核心结论
- TEVAR术后30天内可能发生心力衰竭,发生率约2.23%。
- 主动脉僵硬度增加及血流动力学改变减少冠脉供血可能是机制之一。
- 建议早期药物干预并加强围术期心脏监测。
研究设计与样本
- 系统检索PubMed、Web of Science、Scopus和Cochrane library,初检1231篇,最终纳入11项研究。
- 采用荟萃分析,以TEVAR术后心力衰竭原始发生率为主要终点。
- 因研究间存在显著异质性,采用随机效应模型。
主要发现
- 术后30天内心力衰竭发生于30,680例患者中的684例,原始发生率为2.23%。
- 异质性显著:I2=99.999%,τ2=3.905×10-4,P<0.001。
- 存在显著发表偏倚:Egger's test z=2.156,P=0.031。
关键数值与推荐
- TEVAR术后30天内心力衰竭原始发生率为2.23%(684/30,680)。
临床怎么用
- TEVAR术后应警惕心力衰竭,尤其对已有心血管风险的患者加强围术期和术后心脏监测。
- 支架植入后关注血流动力学优化,必要时早期启动药物干预。
局限性
- 纳入研究间存在显著异质性(I2=99.999%)。
- 观察到显著发表偏倚(Egger's test P=0.031)。
- 长期心力衰竭发生率尚需随机对照试验和更长随访评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thoracic endovascular aortic repair (TEVAR) is a minimally invasive technique for the treatment of thoracic aortic aneurysms (TAA). We hypothesized that alteration of blood hemodynamics in the thoracic aorta caused by stent implantation can possibly lead to hypertension and reduced coronary flow leading to the induction of heart failure (HF). The search in PubMed, Web of Science, Scopus, and the Cochrane library for studies containing data about the occurrence of HF after TEVAR resulted in 1231 articles of which 11 fulfilled the inclusion criteria. A meta-analysis was undertaken with the raw incidence of HF post-implantation as the primary endpoint. This occurred, in the first 30 days, to 684 out of 30,680 total patients (2.23%), and the raw incidence rate of HF was 0.03 [0.02-0.04], p<0.001. The random effects model was used because the examined studies had significant heterogeneity (I2=99.999%, τ2=3.905×10-4, p<0.001. In addition, significant publication bias was observed (Egger's test z=2.156, p=0.031). HF may develop in 30 days post-TEVAR possibly because of the increased aortic stiffness and the subsequent heamodynamic alterations which reduce the coronary blood supply. Thus, it may be necessary to initiate early pharmacological intervention while further research with randomized controlled trials with longer follow-up is warranted for the evaluation of the incidence of HF in the long term after TEVAR.Clinical ImpactOur meta-analysis shows that heart failure (HF) can occur in approximately 3% of patients within 30 days after TEVAR, indicating that HF is a clinically relevant but often under-recognized complication. Increased aortic stiffness and subsequent heamodynamic alterations which reduce the coronary blood supply may contribute to the development of HF. Our findings highlight the need for careful peri- and post-operative cardiac monitoring, particularly in patients with pre-existing cardiovascular risk and the need for hemodynamic optimization after stent-graft implantation.
引用
- Moula AI, Spanos K, Xanthopoulos A, et al. Heart Failure Rate After Thoracic Endovascular Aortic Repair (TEVAR). J Endovasc Ther. 2026. PMID: 41709603. doi:10.1177/15266028261420021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。